Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
68,394
Sort by:
Typhoid Fever - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
53 pages
Hidradenitis Suppurativa - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hidradenitis Suppurativa (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Hidradenitis Suppurativa and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
251 pages
Hypoglycemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Hypoglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
87 pages
Nasopharyngitis (Common Cold) - Pipeline Review, H2 2020
US$ 2,000.00
... Nasopharyngitis (Common Cold) (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngitis (Common Cold) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
46 pages
Bacterial Vaginosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Bacterial Vaginosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Vaginosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
75 pages
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H2 2020
US$ 2,000.00
... . The Chemotherapy Induced Nausea and Vomiting (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Nausea and Vomiting and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
97 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
152 pages
Cholera - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
62 pages
Dilated Cardiomyopathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Dilated Cardiomyopathy (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Dilated Cardiomyopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
66 pages
House Dust Mite Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The House Dust Mite Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for House Dust Mite Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
61 pages
Insulin Resistance - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
52 pages
Left Ventricular Dysfunction - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Left Ventricular Dysfunction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Left Ventricular Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
48 pages
Plague - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Plague (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Plague and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
66 pages
Primary Sclerosing Cholangitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Primary Sclerosing Cholangitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Primary Sclerosing Cholangitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
150 pages
Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Venous Leg Ulcers (Crural Ulcer) (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Venous Leg Ulcers (Crural Ulcer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
75 pages
Down Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Down Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Down Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
84 pages
Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Functional (Non Ulcer) Dyspepsia (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Functional (Non Ulcer) Dyspepsia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
36 pages
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Non Alcoholic Fatty Liver Disease (NAFLD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
359 pages
Colitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
July 2020
116 pages
Tourette Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... . The Tourette Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Tourette syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
74 pages
Ischemia Reperfusion Injury - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ischemia Reperfusion Injury (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Ischemia Reperfusion Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
197 pages
Secondary Hyperparathyroidism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Secondary Hyperparathyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Secondary Hyperparathyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
63 pages
Sedation - Pipeline Review, H2 2020
US$ 2,000.00
... . The Sedation (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Sedation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
62 pages
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2020
US$ 2,000.00
... Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
83 pages
Community Acquired Pneumonia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Community Acquired Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Community Acquired Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
170 pages
Degenerative Disc Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Degenerative Disc Disease (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Degenerative Disc Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
72 pages
Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
97 pages
Botulism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Botulism (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Botulism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
36 pages
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline guide also reviews of key players involved in therapeutic development for Uterine Leiomyoma (Uterine Fibroids) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
117 pages
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ventilator Associated Pneumonia (VAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
187 pages
Streptococcus pyogenes Infections - Pipeline Review, H2 2020
US$ 2,000.00
... . The Streptococcus pyogenes Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Streptococcus pyogenes Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
35 pages
Cerebral Palsy - Pipeline Review, H2 2020
US$ 2,000.00
Cerebral Palsy - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H2 2017, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape. Cerebral palsy is a group of disorders that can ...
July 2020
50 pages
Mumps - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Mumps (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Mumps and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
32 pages
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hospital Acquired Pneumonia (HAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
207 pages
Hyperalgesia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Hyperalgesia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Hyperalgesia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
40 pages
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Elephantiasis (Lymphatic Filariasis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Elephantiasis (Lymphatic Filariasis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
30 pages
Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Microscopic Polyangiitis (MPA) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Microscopic Polyangiitis (MPA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
66 pages
Phenylketonuria (PKU) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Phenylketonuria (PKU) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Phenylketonuria (PKU) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
80 pages
Prader-Willi Syndrome (PWS) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Prader-Willi Syndrome (PWS) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Prader-Willi Syndrome (PWS) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
109 pages
Atypical Hemolytic Uremic Syndrome - Pipeline Review, H2 2020
US$ 2,000.00
... Atypical Hemolytic Uremic Syndrome (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under ...
July 2020
128 pages
Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Cluster Headache Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cluster Headache Syndrome (Cluster Headache) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
July 2020
72 pages
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Primary Biliary Cholangitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Primary Biliary Cholangitis (Primary Biliary Cirrhosis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
July 2020
149 pages
Intermittent Claudication - Pipeline Review, H2 2020
US$ 2,000.00
Intermittent Claudication - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Intermittent Claudication - Pipeline Review, H2 2020, p...
July 2020
57 pages
Acyl CoA Desaturase - Pipeline Review, H2 2020
US$ 3,500.00
Acyl CoA Desaturase - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Acyl CoA Desaturase - Pipeline Review, H2 2020'; Acyl CoA Desaturase (Fatty Acid Desaturase or Delta...
July 2020
53 pages
Beta Nerve Growth Factor - Pipeline Review, H2 2020
US$ 3,500.00
Beta Nerve Growth Factor - Pipeline Review, H2 2020 SUMMARY Beta Nerve Growth Factor (Beta NGF or NGF) pipeline Target constitutes close to 10 molecules. The latest report Beta Nerve Growth Factor - P...
July 2020
61 pages
Caspase 3 - Pipeline Review, H2 2020
US$ 3,500.00
Caspase 3 - Pipeline Review, H2 2020 SUMMARY Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) pipeline Target constitutes close to 1...
July 2020
80 pages
Hepcidin - Pipeline Review, H2 2020
US$ 3,500.00
Hepcidin - Pipeline Review, H2 2020 SUMMARY Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) pipeline Target constitutes close to 5 molecules. The latest re...
July 2020
41 pages
Histone Deacetylase 8 - Pipeline Review, H2 2020
US$ 3,500.00
Histone Deacetylase 8 - Pipeline Review, H2 2020 SUMMARY According to the recently published report 'Histone Deacetylase 8 - Pipeline Review, H2 2020'; Histone Deacetylase 8 (Histone Deacetylase Like...
July 2020
27 pages
